Vsee Health, Inc.
VSEE· OTC
Filed May 15, 2023 · 10-Q · 45 days after period end · 0001104659-23-060899
| Metric | Q1 2023 | Q1 2022 |
|---|---|---|
| Revenue | $1.58M | — |
| Net Income | -$529.96K | -$527.36K |
| EPS Diluted | -$0.05 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vsee Health, Inc. · CIK 1864531 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 15, 2023 · 45 d after period end